In this episode of Idea Collider, host Mike Rea interviews Dr. Christian Rommel from Bayer. Dr. Rommel discusses his journey in molecular oncology from the Max Planck Institute, through roles at Roche, to overseeing global R&D at Bayer. He shares insights on turning scientific discovery into novel medicines, collaboration between scientists and commercial teams, and the importance of maintaining scientific integrity. Dr. Rommel also delves into the impact of AI in drug development, the potential of genetic medicines, and the complexities of launching new medicines on a global scale. The conversation also touches on embracing failure, internal and external partnerships, and the evolving landscape of clinical translation.
00:00 Introduction and Guest Welcome
00:25 Christian Rommel's Journey in Oncology
03:02 The Importance of Collaboration in Innovation
05:16 Balancing Risk and Reward in Drug Development
18:07 The Role of AI and Data in Modern R&D
22:33 Partnerships and External Learning
26:16 Balancing Legacy and Innovation in Biotech
27:18 Global Expansion and Leadership Diversity
27:27 Courage in Biotech Management
27:54 Inspiration from Roche Genentech
30:26 Commitment to Product Supply and Market Readiness
32:23 Challenges of Global Launches
35:53 Emerging Trends in Pharma: AI and Genetic Medicines
42:20 Decision-Making in Pharma
47:30 Reflections on Academic and Professional Journey
Don't forget to Like, Share, Subscribe, Rate, and Review!
Keep up with Christian Rommel;
LinkedIn: https://www.linkedin.com/in/christian-rommel/
Website: https://www.bayer.com/en/innovation/science-research-and-innovation
Follow Mike Rea On;
Website: https://www.ideapharma.com/
LinkedIn: https://www.linkedin.com/in/bigidea/
Listen to more fantastic podcast episodes: https://podcast.ideapharma.com/